SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-23-000051
Filing Date
2023-03-02
Accepted
2023-03-02 09:20:23
Documents
15
Period of Report
2023-03-02
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20230302.htm   iXBRL 8-K 56452
2 EX-3.1 ex31-arcertificateofincorp.htm EX-3.1 19971
3 EX-3.2 ex32-mergerbylaws_v2.htm EX-3.2 89759
  Complete submission text file 0001385508-23-000051.txt   368518

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20230302.xsd EX-101.SCH 2150
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20230302_def.xml EX-101.DEF 15460
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20230302_lab.xml EX-101.LAB 29892
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20230302_pre.xml EX-101.PRE 16121
9 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20230302_htm.xml XML 12287
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 23696670
SIC: 2834 Pharmaceutical Preparations